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Abstract
Background Serious mental illness (SMI) is a set of disabling conditions associated with poor outcomes and high healthcare 
utilisation. However, little is known about patterns of utilisation and costs across sectors for people with SMI.
Objective The aim was to develop a costing methodology and estimate annual healthcare costs for people with SMI in 
England across primary and secondary care settings.
Methods A retrospective observational cohort study was conducted using linked administrative records from primary care, 
emergency departments, inpatient admissions, and community mental health services, covering inancial years 2011/12–
2013/14. Costs were calculated using bottom-up costing and are expressed in 2013/14 British pounds (GBP). Determinants 
of annual costs by sector were estimated using generalised linear models.
Results Mean annual total healthcare costs for 13,846 adults with SMI were £4989 (median £1208), comprising 19% from 
primary care (£938, median £531), 34% from general hospital care (£1717, median £0), and 47% from inpatient and com-
munity-based specialist mental health services (£2334, median £0). Mean annual costs related speciically to mental health, 
as distinct from physical health, were £2576 (median £290). Key predictors of total cost included physical comorbidities, 
ethnicity, neighbourhood deprivation, SMI diagnostic subgroup, and age. Some associations varied across care context; for 
example, older age was associated with higher primary care and hospital costs, but lower mental healthcare costs.
Conclusions Annual healthcare costs for people with SMI vary signiicantly across clinical and socioeconomic characteris-
tics and healthcare sectors. This analysis informs policy and research, including estimation of health budgets for particular 
patient proiles, and economic evaluation of health services and policies.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4025 8-019-00530 -2) contains 
supplementary material, which is available to authorized users.
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Key Points for Decision Makers 
This is the irst documentation of the spectrum of health-
care costs across sectors for people with serious mental 
illness (SMI) using individual-level data.
People utilising care for SMI incur high healthcare costs, 
although there is substantial variation across the care 
pathway.
Understanding which patient proiles incur costs in 
which sectors can help policymakers plan health budgets 
and inform policy levers to manage resource use across 
the care pathway.
 J. Ride et al.
1 Introduction
1.1  Background/Rationale
Serious mental illness (SMI) comprises a set of chronic con-
ditions that afect mood, emotion, cognition and motivation 
and all aspects of life including employment, relationships, 
housing, and personal care [1]. UK healthcare policy deines 
SMI as schizophrenia, bipolar disorder, and other non-
organic psychoses [2]; 0.72% of the population in England 
will receive a diagnosis of schizophrenia at some point in 
their lives [3], and 1–2% will receive a diagnosis of bipolar 
disorder [4]. People with SMI have poorer physical health 
compared to the general population, with a higher preva-
lence of common chronic disorders and multi-morbidity, and 
a lower life expectancy by around 20 years, and often die 
of preventable physical illnesses [5–9]. People with SMI 
have high rates of healthcare utilisation, including accident 
and emergency (A&E) attendances and hospital admissions, 
for both physical and mental health problems [10–13], and 
the multiplicity of co-morbid health conditions raises total 
healthcare costs [14].
A number of studies have examined the direct costs of 
SMI to the healthcare system as well as the wider indirect 
costs to society [15–22]. Direct costs include the use of 
hospital services, drugs, staf time, ambulances, and com-
munity care; for schizophrenia alone these costs can range 
from 0.5 to 3.5% of national healthcare expenditures [19]. 
Indirect costs include reduced labour supply, premature 
mortality, reduced health-related quality of life, lost out-
put, lost tax revenue, transfer payments, and unpaid care 
by family or friends [21]. The total monetary costs in Eng-
land for schizophrenia and psychoses have been estimated 
at £11.8 billion in 2012, and for bipolar disorder, they have 
been estimated at £5.2 billion in 2007 (equivalent to £6.04 
billion in 2012).
Studies have used diferent costing methodologies to esti-
mate direct costs of mental health treatment and the main 
cost drivers thereof. Cost estimation studies tend to use a 
gross-costing methodology that often relects reimburse-
ment amounts, whereas micro-costing methods involve the 
enumeration of all resources consumed by a patient. A sys-
tematic review by Wolf et al. [23] examining the association 
between mental healthcare hospital costs and patient charac-
teristics considered costing approaches in mental healthcare 
more broadly, not just for SMI. It found that studies difered 
in their estimation of resource use and valuation. The paper 
also identiied six patient characteristics as key cost drivers 
of hospital costs, one being the presence of psychotic or 
afective symptoms. Studies using a micro-costing approach 
[24, 25] focused on examining diferences in characteristics 
between high-cost users and the rest of the cost distribution. 
These show that high-cost users of mental healthcare (incur-
ring the top 10% of costs) account for a disproportionately 
large share of healthcare costs (74–87%), and that the major-
ity have a diagnosis of SMI (particularly schizophrenia).
Despite the considerable disease burden and costs for this 
patient group, there has been little empirical cost estimation 
research speciically focusing on the SMI population, using 
linked individual-level data and micro-costing approaches, 
and analysing data for more than 1 year. A further gap in 
the literature has been the estimation of multi-sectoral costs 
for people with SMI examining which elements of the care 
pathway are the main cost drivers across sectors. Most stud-
ies examining cost drivers of patient care for this popula-
tion group have focused on inpatient care and/or on total 
costs. Understanding where the largest components of cost 
fall across diferent sectors, as well as identifying the main 
cost drivers, is important to help design more cost-efective 
treatment pathways and more integrated care for this patient 
group.
We address these gaps in the evidence by seeking to (1) 
develop a costing methodology for multi-sectoral health-
care costs for people with SMI in England based on the best 
micro-level data currently available, (2) estimate annual 
healthcare costs for people with SMI in England across pri-
mary and secondary care, and (3) identify predictors of costs 
across each sector.
The key contributions of this study are that (1) it is the 
irst study to use linked administrative records for the full 
care pathway of patients with SMI in the English National 
Health Service (NHS), covering primary care, emer-
gency departments, inpatient admissions, and commu-
nity mental health services; (2) it covers 3 inancial years 
(2011/12–2013/14), where previous studies have tended to 
estimate costs for a single year; (3) it employs a detailed bot-
tom-up costing methodology; and (4) it provides evidence 
on the key clinical and socio-economic cost drivers across 
diferent healthcare sectors.
2  Methods
2.1  Study Design
This observational cohort study used healthcare service 
administrative data from primary care, inpatient admis-
sions, A&E presentations, and community mental health 
services linked at the individual patient level. Annual costs 
of healthcare utilisation in each of these sectors was esti-
mated using a bottom-up approach for 3 inancial years from 
2011/12 to 2013/14, applying national average unit costs for 
the 2013/14 inancial year from the perspective of the NHS.
To provide some indication of the proportion of health-
care costs related to mental health as distinct from physical 
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health for this population, we identiied a subset of costs 
that could be clearly labelled as “related”, comprising all 
specialist mental healthcare costs (inpatient and outpatient) 
and mental health drug costs in primary care.
2.2  Data Source and Sample
Data for this study were accessed through the Clinical Prac-
tice Research Datalink (CPRD), a dataset of records from 
primary care practices in the UK [26]. Data on all patients at 
participating practices are included unless a patient requests 
to have her/his data excluded. Practices in England can also 
allow their records to be linked to hospital records in the 
Hospital Episodes Statistics (HES) and community mental 
health service records in the Mental Health Minimum Data-
set (MHMDS).1 CPRD data are broadly representative of the 
English population regarding age and gender [27]. CPRD 
provided anonymised primary care data of patients identiied 
as having SMI based on Read codes2 in routinely recorded 
CPRD data, linked at the individual patient level to data 
from HES and MHMDS for those patients. Supplementary 
Table 1 provides the Read codes used to identify diagnostic 
categories of SMI; see the electronic supplementary mate-
rial. Supplementary Figure 1 outlines how the sample was 
formulated for this study. Supplementary Table 2 provides 
an overview of the sources of utilisation data and unit costs. 
Supplementary Table 3 outlines the mean visit duration for 
primary care visits of diferent types.
2.3  Primary Care Costs
Primary care utilisation data were extracted from CPRD 
records based on Read codes for three types of primary care 
activity: consultations, drugs prescribed, and diagnostic 
tests.
Unit costs for consultations were obtained from national 
estimates of the cost per minute of general practitioner (GP) 
and practice nurse time for 2014 [29]. We used visit duration 
data rather than a standard visit cost because of evidence 
suggesting that consultations for patients with mental health 
problems are longer than average [30–33]. We considered 
multiple visits in a day for a patient to a single staf member 
as duplicates, but allowed for visits to diferent staf mem-
bers on the same day. See the electronic supplementary 
material for additional detail.
The costs of drug prescriptions were derived from the 
Prescription Costs Analysis3 for 2014, which applied the 
British National Formulary (BNF) edition 66 [34] classi-
ication system. Prescription volume was taken from the 
Therapy section of the CPRD dataset. We used data at the 
BNF subparagraph level where available, otherwise at the 
most speciic BNF level available (paragraph, section, or 
chapter level).4
National average unit costs for diagnostic tests were taken 
from the NHS Reference Costs for the inancial year 2013/14 
[35], calculated retrospectively each year to identify the full 
cost of diagnostic imaging, diagnostic services, pathology 
services, and outpatient procedures. Utilisation volume of 
each test was taken from Read terms recorded in the Test 
section of the CPRD dataset. These were classiied fol-
lowing clinicians’ advice into groups that corresponded to 
the NHS Reference Costs categories.5 Supplementary ile 
Test_unit_allocations_and_costs.xlsx lists the Read terms 
and how they were classiied into Reference Cost categories 
(see the electronic supplementary material).
2.4  Community Mental Health Service Costs
We used a subset of the activity recorded in MHMDS as 
measures of utilisation of community mental health services. 
Speciically, we counted healthcare professional contacts 
(consultations), Care Programme Approach (CPA) reviews, 
electroconvulsive therapy (ECT) sessions, and day attend-
ances, and assigned unit costs reported by the Personal 
Social Services Research Unit (PSSRU) and the Electronic 
Staf Record [36].
The cost of consultations depends on the staf type and 
the duration of the contact (for details on how we dealt with 
missing and zero duration see the electronic supplementary 
material). Based on advice regarding usual practice, we 
restricted the number of consultations per day to a maxi-
mum of two for each type of staf member to avoid duplicate 
1 This dataset has changed names over time; for the period we used, 
2011/12–2013/14, it was called the Mental Health Minimum Data-
set (MHMDS). In September 2014, it became the Mental Health and 
Learning Disabilities Data Set (MHLDDS). From 2016/17, it became 
the Mental Health Services Data Set (MHSDS). See http://webar 
chive .natio nalar chive s.gov.uk/20171 01105 2615/http://conte nt.digit 
al.nhs.uk/artic le/7439/Menta l-Healt h-Servi ces-Data-Set-Archi ved-
Speci icat ion [accessed 21 February 2019].
2 Read codes are a clinical coding system used in primary care in the 
UK to classify diseases, patient characteristics, procedures, and tests 
[28].
3 This provides the Net Ingredient Cost per item according to the 
Drug Tarif. It does not include any discounts, dispensing fees, or 
adjustment for income, and is based on the usual quantity dispensed 
for that drug.
4 This approach did not account for other items listed in CPRD as 
“therapy” that are not included in the BNF, such as dressings or glu-
cose test strips.
5 For example, Read terms (descriptive terms attached to Read 
codes) for blood tests recorded in CPRD data included “Liver func-
tion test”, and “Serum creatinine”, which were both classiied as 
“Clinical biochemistry”.
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recordings. Regarding CPA reviews, MHMDS provides only 
the date and not the staf involved or duration. We assumed, 
following clinical advice, that reviews (which are supposed 
to be multidisciplinary) involve a psychiatrist and a nurse 
and last 30 min, a lower bound estimate. Cost per ECT ses-
sion was based on past costings updated to 2013/14 values 
using the hospital and community health services pay and 
price inlation series [37]. Day attendance cost was based 
on the cost of day care provided by local authority social 
services for people with mental health problems [29].
2.5  Hospital Costs
Admissions to specialist mental health inpatient facilities are 
recorded in MHMDS, and admissions to general hospitals 
(including admissions to non-specialist mental health pro-
viders) are recorded in HES. We costed these two separately 
using national average costs for the type of admission.
2.5.1  Admissions to Specialist Mental Health Inpatient 
Facilities
The cost of a specialist mental health admission depends 
on its duration and the category of mental health prob-
lem or needs (termed the “cluster”) to which the patient is 
assigned, since the Reference Costs of admitted days vary 
by the 21 mental health clusters that exist in the classiica-
tion system [35]. Admissions recorded in MHMDS cover 
all admissions to specialist mental health inpatient facili-
ties and list duration, but not the cluster allocation. Instead, 
we used the closest start of a cluster episode 6 or date of 
Mental Health Clustering Tool7 to determine the cluster. We 
excluded admissions with the same start and end dates as 
these were likely to represent recording errors, and for the 
14% of admissions without an assigned cluster, we used a 
weighted average cost across all clusters. For further detail, 
see the electronic supplementary material.
2.5.2  General Hospital Costs
We identiied inpatient hospital admissions and A&E presenta-
tions from HES records. The classiication system for hospital 
activity in England is Healthcare Resource Groups (HRGs), 
which are similar to Diagnosis-Related Groups (DRGs) used 
in other jurisdictions. In the electronic supplementary material, 
we explain how inpatient episodes of care and A&E attend-
ances are grouped into HRGs relecting type of activity (inpa-
tient or A&E HRGs), additional high-cost inpatient proce-
dures, and long inpatient stays. Costs for these activities were 
taken from the hospital-reported Reference Costs.
The allocation of episodes to HRGs was carried out using 
the costing grouper software which is freely available on the 
NHS Digital website [40]. We grouped all the activity using 
the 2012/13 version of the HRGs design and the correspond-
ing 2012/13 Reference Costs to obtain costs for each activity, 
then used the hospital and community health services pay and 
price inlation index [41] to express costs in 2013/14 prices. 
For episodes with missing or invalid essential data ields, the 
grouper returns an error HRG code. After minor adjustments 
and imputation of some non-essential ields, the error rate for 
our sample was reduced to about 7% for inpatient episodes 
and 10% for A&E presentations. Although HES includes 
admissions to specialist mental health facilities, these were 
not costed because these were captured through MHMDS, 
but mental health conditions treated by non-specialist mental 
health providers (HRGs starting with “WD”) were included 
in general hospital costs. Using the inpatient episode start 
and end dates, costs were apportioned into the inancial years 
2011/12–2013/14. Where an episode of care extended over 
2 years, we attributed costs to each year based on the propor-
tion of episode days in each of the 2 years.
2.6  Explanatory Variables
Read codes in CPRD data were used to identify patient char-
acteristics. SMI diagnoses were grouped according to clini-
cal advice into categories of “schizophrenia and other psy-
choses” and “bipolar disorder and afective psychosis”, with 
some patients having diagnostic codes from both groups at 
diferent times. A variable was formulated to indicate the 
number of years since diagnosis when the patient entered 
observation in the study. The 2010 Index of Multiple Dep-
rivation (IMD) quintile for the patient’s area of residence 
served as an indicator of socioeconomic area deprivation. 
Based on the primary care practice location, two variables 
indicating the distance from the practice to the nearest acute 
hospital and inpatient mental health facility and another 
indicating the rurality category of the practice were derived.8
6 Cluster episode duration: The number of days that a patient has 
remained on the same cluster regardless of whether Mental Health 
Clustering Tool assessment reviews have taken place. See Annex B in 
NHS England [38].
7 The Mental Health Clustering Tool is an algorithm used to allocate 
patients to a cluster [39].
8 Geographic information was derived by CPRD based on the patient 
residence and practice locations. These links were made by CPRD to 
avoid disclosing location information to the study team. Patient resi-
dence information was linked to IMD quintiles based on the lower-
layer super output area (LSOA) or small neighbourhood area.
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2.7  Statistical Methods
For each patient, event costs were aggregated into annual 
costs by sector and year, efectively obtaining a panel dataset 
of annual costs in primary care, specialist mental health-
care (including inpatient and community-based care), and 
general hospital care (including A&E), with total costs as 
the sum of these three. To investigate patterns of total and 
sector costs across patient and practice characteristics, we 
compared mean costs and examined the distribution of costs 
in each group, and conducted multivariate regression analy-
sis. Explanatory variables were based on factors associated 
with utilisation of healthcare in prior research [24, 25, 42]. 
We used a generalised linear model (GLM) with individual 
random efects, which allows for the non-normal distribution 
of healthcare costs and models the mean directly, avoiding 
the need to transform the data. The choices of distributional 
family and link function were informed by the Park test [43] 
and Pregibon link test [44]. All analyses were conducted in 
Stata v14 [45].
2.8  Sensitivity Tests
As an alternative to using the consultation duration data in 
CPRD and MHMDS, we estimated costs using the average 
duration for diferent types of consultations derived from 
the 2006/07 UK General Practice Workforce Survey that are 
applied by Curtis [29]. For mental health inpatient admis-
sions, we present for comparison the results of costing bed 
days using the weighted average cost per bed day across 
all clusters from the national Reference Costs, rather than 
applying the cluster-speciic cost.
To account for potential sex diferences in the severity of 
schizophrenia [46] and bipolar disorder [47], we estimated 
the model including an interaction term between sex and 
diagnostic grouping.
3  Results
3.1  Sample
The sample consists of 34,484  year-observations 
across 13,846 adults with SMI for the financial years 
2011/12–2013/14. Two-thirds of the sample (66.6%) were 
observed for all 3 years, 15.8% were observed for 2 years 
and 17.6% were observed for one full inancial year. Sup-
plementary Figure 1 shows the numbers of patients at each 
stage of the sample formation.
The irst data column of Table 1 shows the distribution 
of characteristics across the sample. The mean (median) age 
was 52 (50) years, the majority (71%) were white, around a 
third had at least one physical comorbidity, two-thirds had 
comorbid depression, three-quarters were current or ex-
smokers, and 16% had been recently diagnosed with SMI. 
People in the sample were more likely to live in urban areas 
(89%) than rural areas, and in more deprived areas.
3.2  Resource Use and Costs
The mean annual healthcare cost per patient was £4988.87 
(range £0–243,831), with £2575.73 (52%) identiiable as 
related to SMI. Figure 1 shows that total costs decreased 
with age until middle age, and then increased for patients 
aged over 65, while the proportion of costs related to SMI 
steadily decreased with age. For patients 19–35 years old, 
64% of total costs were related to SMI, while for patients 
aged over 65, the proportion was 36%, relecting a greater 
emphasis on management of physical comorbidities.
Table  1 shows that primary care costs (£938, range 
£0–29,720) made up approximately 19% of total mean 
annual costs, general hospital costs (£1717, range 
£0–233,318) comprised 34%, and specialist mental health-
care costs (£2334, range £0–176,502) accounted for 47%. 
Table  2 outlines the annual utilisation of the different 
resource units making up these costs.
Table 1 also provides mean cost per year for subgroups 
of patients: mean total costs increase with age, level of 
deprivation, and number of comorbidities, and are higher 
for white than black or minority ethnicity patients, and for 
patients diagnosed with SMI more recently. Patients with 
both schizophrenia and bipolar-type disorders had higher 
costs than those with schizophrenia-type alone, with bipolar-
type associated with the lowest costs.
3.3  Association of Characteristics with Costs
The Pregibon test supported a log link for GLM (p = 0.104) 
with a Poisson distribution supported by the Park test 
(p = 0.483). The association of each patient and practice 
characteristic with the diference in total annual costs (mar-
ginal efects from random efects GLM) is presented in 
Table 3. After adjusting for other observable characteristics, 
higher costs for patients of white ethnicity (compared with 
black and minority ethnicities), those with higher socioeco-
nomic deprivation, and those with physical comorbidities 
were still seen, as was the pattern of costs across diagnostic 
categories.
Table 3 shows how these patterns difer across health-
care sectors. White ethnicity and having SMI diagnoses from 
both categories were consistently associated with higher 
costs across all sectors. Socioeconomic deprivation was 
associated with higher primary care and mental health costs. 
Older patients had higher primary care and general hospi-
tal costs, but lower mental health costs. Physical comor-
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Table 1  Patient characteristics and mean annual healthcare cost by sector and total
N individuals (%) Total cost Primary care 
cost
General hospital 
cost
Mental health 
service cost
Mean SD Mean SD Mean SD Mean SD
Overall 13,846 4989 14,349 938 1368 1717 6734 2334 10,021
Age
 19–35 2595 (18.7) 5429 16,819 562 951 1521 6303 3346 12,855
 36–45 2835 (20.5) 4744 14,541 785 1223 1312 5825 2647 10,604
 46–55 3025 (21.8) 4747 13,659 977 1427 1370 5758 2401 9762
 56–65 2358 (17.0) 4569 12,213 1094 1544 1777 6841 1698 7566
 ≥ 66 3033 (21.9) 5473 14,380 1205 1472 2564 8426 1704 8817
Sex
 Female 7018 (50.7) 4981 13,142 1097 1530 1760 5832 2124 9059
 Male 6828 (49.3) 4997 15,508 771 1153 1672 7561 2554 10,932
Ethnicity
 Black, minority ethnicities 3981 (28.7) 3340 13,014 665 999 1060 7399 1615 8533
 White 9865 (71.3) 5660 14,806 1049 1479 1985 6424 2627 10,553
Diagnostic grouping
 Bipolar disorder and afective psychosis 5086 (36.7) 4241 11,764 998 1302 1643 5988 1601 7549
 Schizophrenia and other psychoses 7122 (51.4) 5122 15,319 854 1340 1724 7411 2543 10,904
 Both categories 1638 (11.8) 6631 16,787 1100 1622 1903 5842 3628 12,203
Years since diagnosis
 0–1 2221 (16.0) 5422 15,267 882 1331 1805 7271 2735 10,439
 2–5 2673 (19.3) 4792 13,432 906 1378 1598 5729 2289 9738
 > 5 8952 (64.7) 4970 14,437 956 1372 1736 6901 2278 10,026
Index of multiple deprivation quintile
 1, least deprived 2226 (16.1) 4244 12,975 878 1247 1532 6551 1834 8588
 2 2547 (18.4) 4534 12,808 897 1240 1670 6010 1967 8658
 3 2526 (18.2) 5183 14,997 944 1414 1809 6611 2430 10,766
 4 3246 (23.4) 5115 14,087 976 1407 1695 6165 2445 10,022
 5, most deprived 3301 (23.8) 5582 16,017 967 1464 1831 7927 2873 11,242
Number of Charlson comorbidities
 0 8904 (64.3) 4610 14,237 733 1114 1405 5779 2472 10,477
 1 3716 (26.8) 5386 14,078 1160 1510 1987 7090 2239 9261
 2 885 (6.4) 6603 17,055 1758 2061 3133 11,852 1712 8867
 3 or more 341 (2.5) 6840 12,037 1969 2027 3696 7708 1174 7848
Comorbid depression
 No history of depression 5274 (38.1) 4893 15,039 731 1098 1685 7725 2477 10,587
 History of depression 8572 (61.9) 5047 13,915 1063 1495 1736 6057 2248 9662
History of smoking
 Non-smoker 3186 (23.0) 4754 14,820 768 1018 1669 7723 2317 10,124
 Current or ex-smoker 10,660 (77.0) 5057 14,209 987 1451 1731 6418 2339 9992
Rurality of GP practice
 Urban area 12,267 (88.6) 5087 14,666 923 1331 1744 6934 2419 10,244
 Rural area 1579 (11.4) 4241 11,616 1049 1622 1507 4941 1685 8090
Distance from GP practice to nearest acute hospital
 0–3 km 6093 (44.0) 5281 15,353 928 1388 1854 7602 2499 10,357
 > 3–6 km 3858 (27.9) 4840 14,003 879 1199 1639 6181 2322 10,072
 > 6–9 km 1739 (12.5) 4602 13,225 1020 1462 1628 6142 1954 9569
 > 9 km 2156 (15.6) 4750 12,841 1004 1507 1545 5430 2201 9301
 0–3 km 2702 (19.5) 5209 15,244 918 1312 1822 7127 2468 10,482
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and hospital, but those with three or more Charlson index 
comorbidities had lower specialist mental healthcare costs. 
Distance from hospital care and inpatient mental healthcare 
was associated with lower costs in some sectors. Comorbid 
depression and smoking were associated with higher pri-
mary care costs only, and male patients had lower primary 
care costs.
3.4  Sensitivity Tests
As shown in Table 4, if we used average primary care visit 
duration instead of the visit-speciic duration data in CPRD, 
the mean annual primary care cost was higher (£985 instead 
of £938). Changing the costing of mental health admissions 
in MHMDS from cluster-speciic to weighted cluster average 
costs had little efect, with mean annual mental health costs 
increasing from £2334 to £2354.
Table 1  (continued)
N individuals (%) Total cost Primary care 
cost
General hospital 
cost
Mental health 
service cost
Mean SD Mean SD Mean SD Mean SD
Distance from GP practice to nearest inpatient 
mental health service
 > 3–6 km 3550 (25.7) 5172 14,852 918 1323 1903 8254 2351 9942
 > 6–9 km 2563 (18.5) 5426 15,665 878 1246 1778 6592 2770 11,338
 > 9 km 5031 (36.3) 4525 12,709 992 1481 1501 5246 2031 9062
GP general practitioner, SD standard deviation
Fig. 1  Mean annual cost over age groups, comparing total costs and 
related costs. CI conidence interval, SMI serious mental illness
Table 2  Resource utilisation within each sector per year
A&E accident and emergency, ECT electroconvulsive therapy, GP general practitioner
Sector Resource unit Annual utilisation Mean annual cost
Mean Median
Primary care GP—face to face clinic visit 4.8 3 £233.27 (all primary care visits)
GP—telephone visit 0.8 0
GP—face to face home visit/other 0.2 0
Nurse—face to face clinic visit 1.7 1
Nurse—telephone visit 0.07 0
Nurse—face to face home visit/other 0.05 0
Tests (pathology, radiology, etc.) 8.6 7 £52.41
Drug prescriptions 64.4 33 £651.95
Specialist mental health Visits 13.2 0 £900.38 (outpatient care)
Day attendances 0.4 0
ECT sessions 0.02 0
Reviews 0.9 0
Mental health inpatient bed days 4.1 0 £1433.94
General hospital Inpatient bed days in general hospital 6.6 0 £1654.97
A&E presentations 0.5 0 £61.95
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Table 3  Association of patient and practice characteristics with diferences in costs by sector (average marginal efects, £ per year)
Total costs (95% CI) Primary care (95% CI) General hospital (95% CI) Mental health (95% CI)
Age
 Base: 19–35
 36–45 − 793.05* (− 1553.38, − 
32.73)
221.98*** (159.22, 
284.74)
− 224.65 (− 521.59, 
72.29)
− 711.27** (− 1248.39, − 
174.15)
 46–55 − 747.01 (1500.54, 6.51) 383.46*** (318.63, 
448.29)
− 167.94 (− 481.58, 
145.71)
− 841.04** (1371.16, − 
310.91)
 56–65 − 1140.77** (− 1878.66, 
− 402.89)
421.99*** (352.48, 
491.50)
115.06 (− 213.49, 443.62) − 1550.06*** (− 2059.92, 
− 1040.20)
 ≥ 66 − 525.11 (− 1297.68, 
247.46)
389.56*** (324.36, 
454.76)
637.17** (277.74, 996.59) − 1486.22*** (− 2016.29, 
− 956.16)
Sex
 Base: female
 Male 68.09 (− 356.23, 492.41) − 215.53*** (− 259.00, − 
172.05)
76.79 (− 124.04, 277.62) 168.31 (− 119.27, 455.90)
Ethnicity
 Base: black, minority 
ethnicities
 White 2369.24*** (1941.31, 
2797.17)
315.13*** (273.94, 
356.33)
887.96*** (660.82, 
1115.11)
1170.84*** (891.51, 
1450.16)
Diagnostic grouping
 Base: bipolar disorder 
and afective psychosis
 Schizophrenia and other 
psychoses
908.29*** (496.77, 
1319.81)
− 20.75 (− 67.60, 26.10) 136.83 (− 57.08, 330.73) 803.11*** (525.76, 
1080.45)
 Both categories 2380.38*** (1647.39, 
3113.36)
104.60** (30.15, 179.06) 294.28* (26.11, 562.45) 2021.41*** (1490.72, 
2552.09)
Years since diagnosis
 Base: 0–1
 2–5 − 569.40 (− 1315.91, 
177.11)
27.27 (− 47.66, 102.20) − 182.67 (− 521.71, 
156.35)
− 441.74 (− 953.49, 70.01)
 > 5 − 460.57 (− 1,142.22, 
221.07)
− 6.91 (− 69.33, 55.52) − 121.38 (− 454.87, 
212.11)
− 376.78 (− 835.60, 82.04)
Index of multiple depriva-
tion quintile
 Base: 1, least deprived
 2 230.72 (− 404.09, 865.53) 21.49 (− 44.36, 87.33) 129.43 (− 154.57, 413.43) 78.77 (− 361.85, 519.39)
 3 870.90* (163.05, 1578.75) 59.21 (− 9.33, 127.75) 301.40 (− 7.32, 610.13) 506.87* (4.71, 1009.04)
 4 759.92* (109.43, 1410.41) 129.96*** (65.20, 194.72) 227.27 (− 66.68, 521.23) 418.83 (− 33.13, 869.98)
 5, most deprived 1036.13** (345.86, 
1726.40)
150.45*** (82.58, 218.33) 304.18 (− 29.04, 637.40) 580.50* (117.98, 1043.03)
Number of Charlson 
comorbidities
 Base: 0
 1 707.23** (250.80, 
1163.66)
357.91*** (307.08, 
408.75)
490.85*** (273.77, 
707.92)
− 144.03 (− 450.18, 162.12)
 2 1926.56** (803.36, 
3049.77)
766.61*** (645.79, 
887.42)
1252.16*** (571.71, 
1932.60)
− 360.09 (− 1040.44, 
320.26)
 3 or more 1823.86** (647.95, 
2999.76)
926.39*** (736.99, 
1115.79)
1308.09*** (782.10, 
1978.08)
− 1036.79* (− 1885.43, − 
188.14)
Comorbid depression
 Base: no history of 
depression
 History of depression 19.10 (− 419.18, 457.39) 215.82*** (172.21, 
259.42)
− 23.14 (− 224.60, 
178.33)
− 158.88 (− 457.99, 140.23)
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The set of models with an interaction term between sex 
and diagnostic grouping found the interaction between male 
sex and “schizophrenia and other psychoses” to be positive 
and statistically signiicant in the models for total costs and 
mental health costs. The marginal efects from this model 
presented in Supplementary Table 4 show a larger diference 
in costs between the base category of “bipolar disorder and 
afective psychoses” and “schizophrenia and other psycho-
ses” for males than females.
4  Discussion
Estimates of healthcare costs for people with SMI are 
required to inform resource allocation, to model resource 
consumption in health technology assessments, and for 
service planning. Previous analyses of healthcare costs for 
people with SMI have focused on speciic sectors of the 
healthcare system, ofering only a partial picture of overall 
resource use. Furthermore, there are no published costing 
algorithms for SMI care in the English NHS, which may 
explain the limited availability of costing studies in this 
population. To address these issues, we have developed a 
micro-costing methodology to estimate the cost of health-
care services used by people with SMI across primary, gen-
eral hospital and mental healthcare settings in England. We 
applied this methodology to linked individual-level data 
to study the determinants of annual healthcare costs for a 
sample of people with SMI over a 3-year period. To our 
knowledge, this is the irst study to use linked patient-level 
data from electronic health records to study cost variation 
within the SMI population.
We estimate average annual care costs of £4989 per 
patient (in 2013/14 terms, equivalent to £5777 in 2019 terms 
adjusted using the consumer price index). [48] This is sub-
stantially higher than the average annual cost of £1631 for 
a member of the general public of similar age to our study 
average (52 years) [49]. Assuming a point prevalence of SMI 
of 0.9% and a total population of 54.3 million in 2014 [50], 
the total annual cost to the English NHS is £2.44 billion 
Marginal efects from GLM with Poisson distribution and log link with individual random efects
CI conidence interval, GLM generalised linear model, GP general practitioner
*p < 0.05, **p < 0.01, ***p < 0.001
Table 3  (continued)
Total costs (95% CI) Primary care (95% CI) General hospital (95% CI) Mental health (95% CI)
History of smoking
 Base: non-smoker
 Current or ex-smoker − 3.71 (− 539.19, 531.78) 143.87*** (100.41, 
187.33)
− 84.41 (− 362.75, 
193.93)
− 54.61 (− 413.59, 304.38)
Rurality of GP practice
 Base: urban area
 Rural area 409.92 (− 1033.33, 
213.29)
77.99 (− 0.77, 156.75) − 87.46 (− 337.37, 
161.46)
− 435.28 (− 878.18, 7.61)
Distance from GP practice 
to nearest acute hospital
 Base: 0–3 km
 > 3–6 km 343.94 (− 833.53, 145.64) − 82.61** (− 132.44, − 
32.78)
− 192.28(− 411.09, 26.52) − 65.42 (− 402.70, 271.86)
 > 6–9 km − 234.69(− 960.93, 
491.56)
38.42 (− 38.21, 115.06) − 55.75 (− 383.34, 
271.83)
− 245.01 (− 761.12, 271.10)
 > 9 km 104.58 (795.64, 586.48) − 34.01 (− 107.66, 39.65) − 161.97 (− 454.13, 
130.20)
90.33 (418.36, 599.03)
Distance from GP practice 
to nearest inpatient men-
tal health service
 Base: 0–3 km
 > 3–6 km − 21.83 (− 674.61, 
630.94)
27.51 (− 33.92, 88.94) − 1.65 (− 333.31, 330.01) − 53.14 (− 475.30, 369.03)
 > 6–9 km 241.69 (− 502.12, 985.50) − 27.70 (− 90.92, 35.51) − 118.67 (− 436.04, 
198.70)
368.97 (− 143.07, 881.01)
 > 9 km 615.16 (− 1269.50, 39.16) 43.53 (− 23.31, 110.38) − 402.93** (− 690.61, − 
115.26)
− 242.43 (− 693.57, 208.71)
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(equivalent to £2.82 billion in 2019 terms). Previous esti-
mates for schizophrenia and bipolar disorder separately were 
higher (approximately £2.6 billion and £1.9 billion, respec-
tively, in 2013/14 terms) [51, 52], but were prevalence-based 
rather than based on individual-level data linked across NHS 
services.
Costs are highest in the irst 12 months after diagnosis 
and then fall by approximately 11–13% in subsequent years, 
which is consistent with the patterns observed for other 
health conditions [53]. This may be due to higher service use 
during the treatment initiation period following diagnosis, 
reduced risk of subsequent crisis events, dropout from treat-
ment, or gradual adaptation by patients to their health condi-
tion. Moreover, treatment costs can be predicted by several 
patient characteristics such as local area deprivation and eth-
nicity. While most of these characteristics have a consistent 
directional efect across sectors, older age is associated with 
higher costs in primary care but lower costs in specialised 
mental healthcare, suggesting a cross-sectoral shift in the 
cost burden over a patient’s lifetime. Age and diagnostic cat-
egory were also strong predictors of cost in Wolf et al. [23], 
albeit the studies included in that review did not include only 
SMI patients and focused only on inpatient care.
The primary strength of our study is the use of linked 
longitudinal electronic health records covering primary, sec-
ondary and community care, which allows us to implement 
a micro-costing approach to obtain detailed resource use 
estimates. These data have only recently become available 
and provide a comprehensive view of contemporaneous care 
arrangements in the English routine care setting.
There are a number of limitations to our study that arise 
from the speciic data used. The data do not cover (non-
admitted) outpatient care provided by general hospitals, 
drugs prescribed by community mental health services, 
or all social care provided in the community. These cost 
categories are likely to be important as payers are increas-
ingly starting to pool budgets across sectors. The data did 
not include costs of seeking healthcare (such as travel) or 
care outside the NHS, nor measures of disease severity, so 
we cannot ascertain whether severity mediates the associa-
tion between costs and factors such as socioeconomic sta-
tus. While GP practices participating in CPRD have been 
shown to be broadly representative in terms of the age–sex 
composition and socio-economic proile of their patient 
population, we cannot ascertain the representativeness of 
our speciic sample, which may be compromised by the more 
transient nature of care relationships for people with SMI, 
who are often living in precarious circumstances, and the 
requirement to be registered with the practice for at least 
1 year prior to sample inclusion. The NHS requires patients 
to be registered with a GP, so we are unlikely to be missing 
patients managed solely by specialist mental health services. 
In MHMDS, there was an imperfect correlation between 
dates assigned for episodes of care (cluster episodes) and 
dates when healthcare activities were recorded. Moreover, 
in some instances, patients were recorded to be in hospital 
while receiving outpatient care. We made the assumption 
that cluster episode dates were more likely to be wrong and 
that recorded activities were genuine, which may have led 
to overestimated costs.
Table 4  Efect of alternate 
speciications on sectoral cost 
distributions
Sensitivity A: Assumes average duration for all primary care visits as per the 2006/07 UK General Practice 
Work Load Survey. Sensitivity B: Uses weighted average cost per bed day across clusters from the national 
Reference Costs for specialist mental health admissions, rather than cluster-speciic costs
SD standard deviation
Main analysis Sensitivity A Sensitivity B
Total costs
 Mean (SD) 4989 (14,348) 5036 (14,350) 5009 (14,464)
 Median 1208 1266 1208
Primary care costs
 Mean (SD) 938 (1368) 985 (1386)
 Median 531 574
 % of total costs 18.8% 19.6% 18.7%
General hospital costs
 Mean (SD) 1717 (6734)
 Median 0
 % of total costs 34.4% 34.1% 34.3%
Specialist mental health costs
 Mean (SD) 2334 (10,021) 2354 (10,146)
 Median 0 0
 % of total costs 46.8% 46.3% 47.0%
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The measurement of visit costs was imprecise due to 
the absence of band-speciic hourly costs for nurses in the 
PSSRU cost estimates (with all nurses in primary care clas-
siied as band 5), and recording errors of visit duration in 
CPRD. However, our use of the timing of ile opening and 
closing in CPRD does produce estimates that correlate 
well with duration data available from other sources, and 
has now been incorporated into the PSSRU unit cost esti-
mates [41]. This analysis is conducted on data from 2011/12 
to 2013/14, using unit costs for 2013/14. While we have 
inlated the average costs to current values using national 
consumer price inlation igures for the health domain [48], 
other changes may have occurred over that period not in line 
with inlation.
5  Conclusions
Estimates of the direct cost of SMI are important for deci-
sion makers seeking to improve technical and allocative 
eiciency of care services. Information from this study can 
help decision makers in planning services and benchmark-
ing as well as resource allocation. Our study demonstrates 
that the cost of healthcare resource use across primary, 
secondary and community care are determined by a range 
of patient characteristics that are observable in electronic 
health records. Specialised mental healthcare is the main 
component of annual costs for people with SMI.
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